Cardiogen

What Cardiogen is, structurally

Cardiogen is a tetrapeptide with a free N-terminal amine and a free C-terminal acid.

The formula reconciles exactly, and here that does real work. Seven nitrogens comes from four backbone amides plus three from the arginine guanidinium. Alanine, glutamate and aspartate contribute no side-chain nitrogen, so every nitrogen beyond the backbone belongs to that one residue. A sequence without an arginine could not give this formula.

The arginine distinguishes this peptide from others built on the same acidic core. Its guanidinium is the most basic group among the standard amino acids, pKa around twelve and a half, so it stays protonated across the whole working range rather than titrating within it. A histidine would give pH-dependent charge and a lysine deprotonates only under strong alkali; an arginine is effectively permanently positive.

Charge overall tips slightly negative: glutamate, aspartate and the C-terminal acid against the arginine and the free N-terminal amine, so a small net negative rather than the strong one an all-acidic sequence would carry.

The sequence contains no cysteine, no methionine and no aromatic residue, so the formula carries no sulfur and the molecule has no 280 nm chromophore. It is polar and water soluble, though no quantitative figure is quoted here.

Reconstitution and handling

Sterile water is the default solvent, and with no metal centre present PBS or an appropriate assay buffer are equally suitable. Add diluent down the inside wall of the vial, swirl gently, and let it stand until clear. Vortexing adds foaming and nothing else on a peptide this short.

No reducing agent is needed, since the formula contains no sulfur for one to act on.

Adsorption is worth allowing for at low concentration, and low-protein-binding tubes reduce measured loss. A small peptide with balanced charge and no hydrophobic surface has limited affinity for polypropylene.

This is laboratory preparation chemistry, not dosing, administration, or protocol guidance of any kind.

Storage and stability

Store the lyophilized powder at -20 degrees C, sealed, desiccated and protected from light, and let a cold vial warm before opening. Reconstituted, hold at 2 to 8 degrees C, or aliquot and freeze rather than thawing repeatedly.

The liability profile is narrow. No cysteine to oxidise, no methionine to form a sulfoxide, no tryptophan to photo-oxidise, no asparagine or glutamine to deamidate. Oxidation is not a concern at all, so air exposure matters far less here than for a sulfur- or tryptophan-containing peptide.

What remains is the aspartate at position three, which can cyclise to a succinimide and reopen as isoaspartate, rearranging the backbone at unchanged mass. Rate depends on the following residue, and here that is arginine, whose bulky side chain hinders the closure sterically, making this a slower variant than one followed by glycine. Cold, dry, near-neutral storage remains the control.

These are storage conditions for the material, not dosing or administration guidance.

How Cardiogen is tested

Reversed-phase HPLC establishes chromatographic purity as area percent. With no aromatic residue in the sequence there is no absorbance at 280 nm, so detection sits in the low UV near 214 nm where the amide bond absorbs.

Retention is worth anticipating. A short peptide carrying a permanently charged guanidinium and three acidic groups is highly polar, retaining weakly on C18, so high-aqueous conditions and ion pairing matter more than for a neutral peptide of similar length. Trifluoroacetate is the usual ion-pairing agent and pairs particularly effectively with a guanidinium, which is one reason it is hard to remove from arginine-containing peptides afterwards.

Area percent is a chromatographic measure rather than peptide content by weight. Solid-phase synthesis delivers a salt, commonly trifluoroacetate or acetate, and on a 489 g/mol peptide that counter-ion is a proportionally large share of the vial contents.

Mass spectrometry confirms identity, with the blind spot common to aspartate-containing sequences: isoaspartate is isobaric, so the rearrangement is invisible to mass and only chromatography shows it. Arginine-containing peptides also ionise strongly in positive mode, the guanidinium retaining charge readily, which makes detection straightforward.

These describe general methodology, not a claim about any particular batch.

Handling FAQ

Why does the arginine matter more than a lysine would? Because it never loses its charge. A guanidinium group has a pKa around twelve and a half, so it stays protonated across the whole ordinary working range, whereas a lysine can begin to deprotonate under alkaline conditions and a histidine titrates within the normal range. The molecule's charge state is therefore stable across pH in a way it would not otherwise be.

Is the main degradation route visible by mass spectrometry? No. Aspartate-to-isoaspartate rearrangement moves the backbone without adding or removing atoms, so the mass is unchanged. Chromatographic separation is what resolves it.

Full specifications for Cardiogen.